Bioactive Coating with Clindamycin, VEGF-165, and TGF-β1 for Supporting Bone Tissue Regeneration

Published: 6 August 2025| Version 1 | DOI: 10.17632/m9xh8wysc5.1
Contributors:
Dagmara Slota, Karina Niziołek, Agnieszka Sobczak-Kupiec

Description

The results of the research on the physicochemical analysis of bioactive composite coatings as a drug carrier, intended for bone tissue regeneration. The analysis and description of the results are discussed in the publication "Bioactive Coating with Clindamycin, VEGF-165, and TGF-β1 for Supporting Bone Tissue Regeneration". The results were obtained as part of the “Multifunctional biologically active composites for applications in bone regenerative medicine” project, carried out within the TEAM-NET program of the Foundation for Polish Science, financed by the European Union under the European Regional Development Fund (grant no. POIR.04.04.00-00-16D7/18).

Files

Institutions

Categories

Biomaterial, Drug Delivery, Bone, Biomaterial Coating, Ceramic Composite, Polymer Composite

Funders

Licence